Syngene’s Hunt Says India Now Offers Intellectual Arbitrage to Firms
Remdesivir production boosted our June quarter growth strongly-Syngene CEO
Syngene in Fortune India’s Top 100 wealth creators list
Syngene sees ‘mid-teen’ growth this fiscal on strong pent-up demand
Out-thinking a pandemic – Mahesh Bhalgat COO, Syngene
Building expertise in advanced technologies
Collaborations, funding spur research and development
Hope and prayer Race for the Covid-19 vaccine
Syngene brings out novel approach to treat acute myeloid leukaemia
‘Diversity in Pharma & Biotech’, a special feature by Pharma Bio World covering 2 Syngene scientists
